CBCC Global Research

CBCC Global Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CBCC Global Research is a US-headquartered, India-centric CRO founded in 2010, offering end-to-end clinical development services. It leverages its extensive site network and over 275 professionals in the US and India to execute trials, boasting experience in over 250 trials across 400+ sites. The company is positioned as a 'rescue trial' expert and is undergoing a strategic rebrand to REV Clinical, indicating a potential shift in market positioning and service offerings.

OncologyOphthalmologyNeuro-PsychiatryRare DiseaseDermatology

Technology Platform

Integrated clinical trial service platform encompassing Phase I-IV trial management, regulatory affairs, biometrics, medical writing, and specialized patient-based PK/BE studies. Leverages an extensive network of 500+ clinical sites and operational processes optimized for the Indian and global trial environment.

Opportunities

The growing trend of pharmaceutical R&D outsourcing and India's increasing role as a preferred location for cost-effective, high-quality clinical trials present a significant growth opportunity.
Specialization in complex areas like oncology and rare diseases, along with the 'rescue trial' niche, allows for higher-value engagements.

Risk Factors

Operational risks include regulatory changes in India and maintaining quality across a dispersed site network.
The company faces intense competition from both global CRO giants and local Indian firms, requiring constant differentiation beyond cost.
Client dependency and cyclicality in pharma R&D spending also pose financial risks.

Competitive Landscape

CBCC Global operates in the highly competitive global CRO market, competing with large multinational firms (e.g., IQVIA, Parexel, ICON) and a crowded field of regional Indian CROs. Its differentiation is based on its deep India operational expertise, full-service offering, therapeutic specialization, and 'rescue trial' capabilities.